Page last updated: 2024-10-28

hydralazine and Neointima

hydralazine has been researched along with Neointima in 1 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Neointima: The new and thickened layer of scar tissue that forms on a PROSTHESIS, or as a result of vessel injury especially following ANGIOPLASTY or stent placement.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inaba, S1
Iwai, M1
Furuno, M1
Kanno, H1
Senba, I1
Okayama, H1
Mogi, M1
Higaki, J1
Horiuchi, M1

Other Studies

1 other study available for hydralazine and Neointima

ArticleYear
Temporary treatment with AT1 receptor blocker, valsartan, from early stage of hypertension prevented vascular remodeling.
    American journal of hypertension, 2011, Volume: 24, Issue:5

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Arteries; Blood Vessels; Disease

2011